NCT02231879: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 76 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02231879 |
|---|---|
| Title | A Phase III Double-Blind Randomized Crossover Study of Plerixafor Versus G-CSF in the Treatment of Patients With WHIM Syndrome. |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 14, 2014 |
| Completion date | Oct. 8, 2020 |
| Required reporting date | Oct. 8, 2021, midnight |
| Actual reporting date | Dec. 23, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 76 |